Bionime Corp (4737) - Total Liabilities

Latest as of December 2025: NT$3.95 Billion TWD ≈ $124.41 Million USD

Based on the latest financial reports, Bionime Corp (4737) has total liabilities worth NT$3.95 Billion TWD (≈ $124.41 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Bionime Corp (4737) net asset momentum to track the company's year-over-year net asset growth rate.

Bionime Corp - Total Liabilities Trend (2009–2025)

This chart illustrates how Bionime Corp's total liabilities have evolved over time, based on quarterly financial data. See 4737 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Bionime Corp Competitors by Total Liabilities

The table below lists competitors of Bionime Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Caribou Biosciences Inc NASDAQ:CRBU	USA	$57.46 Million
Baiksan KO:035150	Korea	₩186.04 Billion
Silver X Mining Corp V:AGX	Canada	CA$37.68 Million
Cape Industries Ltd KQ:064820	Korea	₩4.61 Trillion
Owlet Inc NYSE:OWLT	USA	$50.91 Million
Ajiya Bhd KLSE:7609	Malaysia	RM90.88 Million
Yg Plus Inc KO:037270	Korea	₩103.63 Billion

Liability Composition Analysis (2009–2025)

This chart breaks down Bionime Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bionime Corp (4737) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.75	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.69	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bionime Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bionime Corp (2009–2025)

The table below shows the annual total liabilities of Bionime Corp from 2009 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$3.95 Billion ≈ $124.41 Million	+1.45%
2024-12-31	NT$3.89 Billion ≈ $122.63 Million	+17.68%
2023-12-31	NT$3.31 Billion ≈ $104.20 Million	+13.95%
2022-12-31	NT$2.90 Billion ≈ $91.45 Million	+16.67%
2021-12-31	NT$2.49 Billion ≈ $78.38 Million	+3.05%
2020-12-31	NT$2.41 Billion ≈ $76.06 Million	+2.41%
2019-12-31	NT$2.36 Billion ≈ $74.27 Million	-9.20%
2018-12-31	NT$2.60 Billion ≈ $81.80 Million	+13.01%
2017-12-31	NT$2.30 Billion ≈ $72.38 Million	+11.54%
2016-12-31	NT$2.06 Billion ≈ $64.89 Million	+1.70%
2015-12-31	NT$2.03 Billion ≈ $63.81 Million	-38.99%
2014-12-31	NT$3.32 Billion ≈ $104.60 Million	-3.87%
2013-12-31	NT$3.45 Billion ≈ $108.81 Million	+31.25%
2012-12-31	NT$2.63 Billion ≈ $82.90 Million	+49.00%
2011-12-31	NT$1.77 Billion ≈ $55.64 Million	+552.49%
2010-12-31	NT$270.64 Million ≈ $8.53 Million	+7.74%
2009-12-31	NT$251.19 Million ≈ $7.91 Million	--

About Bionime Corp

TW:4737 Taiwan Medical Instruments & Supplies

Market Cap

$136.35 Million

NT$4.33 Billion TWD

Market Cap Rank

#17947 Global

#936 in Taiwan

Share Price

NT$56.00

Change (1 day)

-0.36%

52-Week Range

NT$51.50 - NT$78.30

All Time High

NT$91.20